Jason  Pitarresi  to  Epithelial-Mesenchymal Transition
                            
                            
                                This is a "connection" page, showing publications  Jason  Pitarresi  has written about  Epithelial-Mesenchymal Transition.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.769
         
        
        
     
 
    
        
        - 
            Peura J, Johnson C, Pitarresi JR. To EMT or Not to EMT: Ablation of Mesenchymal Tumor Cell Lineages Reveals the Essential Role of EMT in Pancreatic Cancer Initiation and Evolution. Cancer Res. 2025 Jun 16; 85(12):2146-2148.
            
            
                Score: 0.930
            
         
        
        - 
            Brown BA, Myers PJ, Adair SJ, Pitarresi JR, Sah-Teli SK, Campbell LA, Hart WS, Barbeau MC, Leong K, Seyler N, Kane W, Lee KE, Stelow E, Jones M, Simon MC, Koivunen P, Bauer TW, Stanger BZ, Lazzara MJ. A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer. Cancer Res. 2024 Jun 04; 84(11):1764-1780.
            
            
                Score: 0.216
            
         
        
        - 
            Norgard RJ, Pitarresi JR, Maddipati R, Aiello-Couzo NM, Balli D, Li J, Yamazoe T, Wengyn MD, Millstein ID, Folkert IW, Rosario-Berrios DN, Kim IK, Bassett JB, Payne R, Berry CT, Feng X, Sun K, Cioffi M, Chakraborty P, Jolly MK, Gutkind JS, Lyden D, Freedman BD, Foskett JK, Rustgi AK, Stanger BZ. Calcium signaling induces a partial EMT. EMBO Rep. 2021 09 06; 22(9):e51872.
            
            
                Score: 0.178
            
         
        
        - 
            Bakir B, Chiarella AM, Pitarresi JR, Rustgi AK. EMT, MET, Plasticity, and Tumor Metastasis. Trends Cell Biol. 2020 10; 30(10):764-776.
            
            
                Score: 0.166
            
         
        
        - 
            Pitarresi JR, Rustgi AK. Mechanisms Underlying Metastatic Pancreatic Cancer. Adv Exp Med Biol. 2019; 1164:3-10.
            
            
                Score: 0.149
            
         
        
        - 
            Weissenrieder JS, Peura J, Paudel U, Bhalerao N, Weinmann N, Johnson C, Wengyn M, Drager R, Furth EE, Simin K, Ruscetti M, Stanger BZ, Rustgi AK, Pitarresi JR, Foskett JK. Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. Cell Rep. 2025 May 27; 44(5):115627.
            
            
                Score: 0.058
            
         
        
        - 
            Marchand B, Pitarresi JR, Reichert M, Suzuki K, Laczk? D, Rustgi AK. PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells. Oncogene. 2019 05; 38(22):4325-4339.
            
            
                Score: 0.037
            
         
        
        - 
            Reichert M, Bakir B, Moreira L, Pitarresi JR, Feldmann K, Simon L, Suzuki K, Maddipati R, Rhim AD, Schlitter AM, Kriegsmann M, Weichert W, Wirth M, Schuck K, Schneider G, Saur D, Reynolds AB, Klein-Szanto AJ, Pehlivanoglu B, Memis B, Adsay NV, Rustgi AK. Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer. Dev Cell. 2018 06 18; 45(6):696-711.e8.
            
            
                Score: 0.036